Influence of age on the clinical outcomes of coronary revascularisation for the treatment of patients with multivessel de novo coronary artery lesions: sirolimus-eluting stent vs. coronary artery bypass surgery and bare metal stent, insight from the multicentre randomised Arterial Revascularisation Therapy Study Part I (ARTS-I) and Part II (ARTS-II)

Victor M. Legrand1, MD; Scot Garg2, MD; Patrick W. Serruys2*, MD; Kari S. Virtanen3, MD; Günter Szurawitzki4, MD; Vassilis Voudris5, MD; Alessandro Fontanelli6, MD; Knut Endersen7, MD; Igor Kranjec8, MD; Tessa Rademaker9, MSc; Christodoulos I. Stefanidis10, MD; Kristel Wittebols11, MSc

1. CHU Sart Tilman, Liège, Belgium; 2. Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands; 3. Helsinki University Central Hospital, Helsinki, Finland; 4. Elisabeth Krankenhaus, Essen, Germany; 5. Onassis Cardiac Surgery Center, Athens, Greec

Aims: We sought to evaluate the prognostic impact of age on the procedural results and subsequent clinical outcomes in patients with multivessel disease (MVD) treated either by coronary art

Sign in to read and download the full article

Login Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

ageingcoronary artery diseaserevascularisationbare metal stentssirolimus-eluting stentssurgery

Share via Facebook Share via Twitter Share via LinkedIn Share by email

Read next article

Double stenting: a method for treating acute stent recoil and luminal filling defects